Cachexia is a complex and extremely variable syndrome characterised by weight loss, anorexia, and negative nitrogen balance and is present in many cancer patients during the course of their disease.' 2 In children the cachexia is usually a result of the treatment rather than of the cancer itself. Moreover the protein requirements of children during therapy for malignancy are unknown, both at diagnosis when there is a large tumour burden and during treatment when there are the effects of anticancer drugs and infection. The aetiology of cachexia in children with cancer is multifactorial. Inadequate intake arising from anorexia, mucositis, or malabsorption due to the effects of anticancer drugs, and systemic metabolic factors arising from the effects of the malignancy, chemotherapy, or infection are likely to be contributory. However, since malignancies are typically very chemosensitive in children, very soon in treatment there is minimal or no tumour burden and therefore the major effect is of chemotherapy.It has been known for some years that survival time is closely related to weight loss"'and that the attendant loss of body protein is associated with increased rates of whole body protein turnover."' There have, however, been conflicting reports.'""5 The great majority of the literature is concerned with studies of adults with cancer and there are very few studies of children. An exception is two studies by Kien and Camitta,89 who, using the single dose "N-glycine technique, showed increased rates of whole body protein turnover in children with newly diagnosed leukaemia and lymphoma. Nutritional support to prevent loss of lean body mass is an integral part of treatment in cancer patients, which frequently takes the form of total parenteral nutrition. Improved nutritional status has a number of positive effects, it results in improved tolerance to chemotherapy in certain types of malignancy,"'2 improved immune competence,2"